Skip to main navigation Skip to search Skip to main content

Subcellular Imaging and Diagnosis of Cancer Using Engineered Nanoparticles

Research output: Contribution to journalArticlepeer-review

Abstract

The advances in the synthesis of nanoparticles with engineered properties are reported to have profound applications in oncological disease detection via optical and multimodal imaging and therapy. Among the various nanoparticle-assisted imaging techniques, engineered fluorescent nanoparticles show great promise from high contrast images and localized therapeutic applications. Of all the fluorescent nanoparticles available, the gold nanoparticles, carbon dots, and upconversion nanoparticles are emerging recently as the most promising candidates for diagnosis, treatment, and cancer monitoring. This review addresses the recent progress in engineering the properties of these emerging nanoparticles and their application for cancer diagnosis and therapy. In addition, the potential of these particles for subcellular imaging is also reviewed here.

Original languageEnglish
Pages (from-to)690-710
Number of pages21
JournalCurrent Pharmaceutical Design
Volume28
Issue number9
DOIs
Publication statusPublished - 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Drug Discovery

Fingerprint

Dive into the research topics of 'Subcellular Imaging and Diagnosis of Cancer Using Engineered Nanoparticles'. Together they form a unique fingerprint.

Cite this